The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
More top news
Satellite images have revealed the extent of the damage to the ancient Temple of Bel in Syria's Palmyra city by Islamic State jihadists.
Nearly half of all young people are bullied at school each day with many left feeling suicidal due to the experience, according to a survey
Thousands of pounds of NHS cash is being spent on holidays, aromatherapy and even summer houses for patients, according to research